CDEK
← All organizations

Amylyx Pharmaceuticals Inc.

For profitWebsite ↗

Also known as: AMYLYX | Amylyx Pharmaceuticals | Amylyx Pharmaceuticals Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2017

First marketed drug

Sep 29, 2022

Last known activity

Dec 31, 2024

Timeline

2010s

  1. Jun 1, 2013

    Amylyx Pharmaceuticals Inc.— Founded

2020s

  1. Sep 29, 2022

    ursodeoxycholic acid— NDA Secondary Org

Drugs by trial phase (4 distinct, 11 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (15)

Details

Founded
Cambridge, MA, US Jun 1, 2013
Last known activity
Dec 31, 2024